We are monitoring the impact of COVID-19 on Asia Pacific CTMS Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 9765
Share on
Share on

Asia Pacific Clinical Trial Management System Market Research Report – Segmented By Delivery Mode, Component, Type of System, End-User, Country (India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Size, Share, Trends and Growth Forecast | 2020 to 2025

Pulished: February, 2020
ID: 9765
Pages: 90

APAC CTMS Market Size

The Asia Pacific Clinical Trial Management System Market is predicted to worth USD 285 million in 2020, which is estimated to grow at a CAGR of 16.2% from 2020 to 2025, as per our report.

In the Asia Pacific, the rising number of clinical trials due to the increasing number of people suffering from infectious diseases is majorly enhancing the growth of the APAC CTMS market. The burden of chronic diseases is significantly increasing in the Asia Pacific, which is directly increasing the need for a new vaccine for diseases. The governments in this region are promoting CTMS to keep records of the clinical trials in their countries. There are many key players in this region which carry out R&D to find betterment in providing CTMS services. 

The cost of the clinical trial management system for installation and maintenance is high, which is slightly impeding the growth rate of the market. It requires different infrastructure hardware, continuous changes in the field of clinical trials, and the maintenance of new data is difficult are considered as the significant challenges to the companies operating in the Asia Pacific CTMS Market.

This research report has been segmented and sub-segmented into the following categories:

  • By Delivery Mode: Web-based CTMS, On-premise CTMS and Cloud-based CTMS
  • By Component: Software, Hardware and Services
  • By End User: Pharmaceuticals, Clinical Research Organization and Other End Users
  • By Type of System: Site-based Licensed, Enterprise-based and Licensed Enterprise-based
  • By Country: India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC

In the Asia Pacific, the Indian CTMS market is one of the fastest-growing markets. The growth in the number of clinical trials happening in India is majorly boosting the market growth. The IT industry in India is well developed; thus, the pharma and biotech companies are collaborating with the IT companies to develop CTMS. The government in India is promoting CTMS to the possible extent, which is enhancing the demand of the market.

China is one of the leaders in the clinical trials. The Chinese CTMS market is next to India in showcasing the fastest growth rate. The technological advancements in China is the primary reason, which is expanding the market in this country. There are many research institutes in China, which are carrying out a clinical trial where CTMS plays a significant role in the institutes.

Australian CTMS Market is expected to have significant growth opportunities in the coming years. Constant economic growth is elevating the demand of the market. 

Companies like Bioclinica, Bio-Optronics Inc., DATATRAK International Inc., ERT Clinical, IBM, Medidata Solutions Inc., MedNet Solutions, Inc., Oracle, Parexel International Corporation and ArisGlobal are playing a leading role in the Asia Pacific CTMS market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Delivery Mode
      1. Web-based CTMS
      2. On-premise CTMS
      3. Cloud-based CTMS
      4. Y-o-Y Growth Analysis, By Delivery Mode
      5. Market Attractiveness Analysis, By Delivery Mode
      6. Market Share Analysis, By Delivery Mode
    2. By Component
      1. Software
      2. Hardware
      3. Services
      4. Y-o-Y Growth Analysis, By Component
      5. Market Attractiveness Analysis, By Component
      6. Market Share Analysis, By Component
    3. By End User
      1. Pharmaceuticals
      2. Clinical Research Organization
      3. Other End Users
      4. Y-o-Y Growth Analysis, By End User
      5. Market Attractiveness Analysis, By End User
      6. Market Share Analysis, By End User
    4. By Type of System
      1. Site-based Clinical Trial Management System
      2. Licensed Enterprise-based Clinical Trial Management System
      3. Y-o-Y Growth Analysis, By Type of System
      4. Market Attractiveness Analysis, By Type of System
      5. Market Share Analysis, By Type of System
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Material Type
        3. By Form
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Material Type
        3. By Form
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Material Type
        3. By Form
    2. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Bioclinica
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Bio-Optronics Inc.
    3. DATATRAK International Inc.
    4. ERT Clinical
    5. IBM
    6. Medidata Solutions Inc.
    7. MedNet Solutions Inc.
    8. Oracle
    9. Parexel International Corporation
    10. ArisGlobal
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Asia Pacific Global Clinical Trial Management System (CTMS) Market, By Delivery Mode, From 2020 to 2025 ( USD Million )
  2. Asia Pacific Web-based CTMS Market By Region, From 2020 to 2025 ( USD Million )
  3. Asia Pacific On-premise CTMS Market By Region, From 2020 to 2025 ( USD Million )
  4. Asia Pacific Cloud-based CTMS Market By Region, From 2020 to 2025 ( USD Million )
  5. Asia Pacific Global Clinical Trial Management System (CTMS) Market, By Component, From 2020 to 2025 ( USD Million )
  6. Asia Pacific Software Market By Region, From 2020 to 2025 ( USD Million )
  7. Asia Pacific Hardware Market By Region, From 2020 to 2025 ( USD Million )
  8. Asia Pacific Services Market By Region, From 2020 to 2025 ( USD Million )
  9. Asia Pacific Global Clinical Trial Management System (CTMS) Market, By End User, From 2020 to 2025 ( USD Million )
  10. Asia Pacific Pharmaceuticals Market By Region, From 2020 to 2025 ( USD Million )
  11. Asia Pacific Clinical Research Organization Market By Region, From 2020 to 2025 ( USD Million )
  12. Asia Pacific Other End-Users Market By Region, From 2020 to 2025 ( USD Million )
  13. Asia Pacific Global Clinical Trial Management System (CTMS) Market, By Type of System, From 2020 to 2025 ( USD Million )
  14. Asia Pacific Site-based Licensed Enterprise-based Market By Region, From 2020 to 2025 ( USD Million )
  15. Asia Pacific Licensed Enterprise-based Market By Region, From 2020 to 2025 ( USD Million )
  16. Japan Global Clinical Trial Management System (CTMS) Market, By Delivery Mode, From 2020 to 2025 ( USD Million )
  17. Japan Global Clinical Trial Management System (CTMS) Market, By Component, From 2020 to 2025 ( USD Million )
  18. Japan Global Clinical Trial Management System (CTMS) Market, By End User, From 2020 to 2025 ( USD Million )
  19. Japan Global Clinical Trial Management System (CTMS) Market, By Type of System, From 2020 to 2025 ( USD Million )
  20. China Global Clinical Trial Management System (CTMS) Market, By Delivery Mode, From 2020 to 2025 ( USD Million )
  21. China Global Clinical Trial Management System (CTMS) Market, By Component, From 2020 to 2025 ( USD Million )
  22. China Global Clinical Trial Management System (CTMS) Market, By End User, From 2020 to 2025 ( USD Million )
  23. China Global Clinical Trial Management System (CTMS) Market, By Type of System, From 2020 to 2025 ( USD Million )
  24. India Global Clinical Trial Management System (CTMS) Market, By Delivery Mode, From 2020 to 2025 ( USD Million )
  25. India Global Clinical Trial Management System (CTMS) Market, By Component, From 2020 to 2025 ( USD Million )
  26. India Global Clinical Trial Management System (CTMS) Market, By End User, From 2020 to 2025 ( USD Million )
  27. India Global Clinical Trial Management System (CTMS) Market, By Type of System, From 2020 to 2025 ( USD Million )
  28. Australia Global Clinical Trial Management System (CTMS) Market, By Delivery Mode, From 2020 to 2025 ( USD Million )
  29. Australia Global Clinical Trial Management System (CTMS) Market, By Component, From 2020 to 2025 ( USD Million )
  30. Australia Global Clinical Trial Management System (CTMS) Market, By End User, From 2020 to 2025 ( USD Million )
  31. Australia Global Clinical Trial Management System (CTMS) Market, By Type of System, From 2020 to 2025 ( USD Million )
  32. South Korea Global Clinical Trial Management System (CTMS) Market, By Delivery Mode, From 2020 to 2025 ( USD Million )
  33. South Korea Global Clinical Trial Management System (CTMS) Market, By Component, From 2020 to 2025 ( USD Million )
  34. South Korea Global Clinical Trial Management System (CTMS) Market, By End User, From 2020 to 2025 ( USD Million )
  35. South Korea Global Clinical Trial Management System (CTMS) Market, By Type of System, From 2020 to 2025 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample